RTI Surgical Spikes After Dodging FDA Warning

Published: Sep 16, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RTI Surgical gets some Wall Street love on announcing that a new FDA inspection confirms changes made at its Florida manufacturing facility. Florida-based RTI Surgical (NSDQ:RTIX) announced this week that a new inspection of its manufacturing facility confirmed that the company had taken the appropriate actions to correct issues cited in an FDA warning letter issued last year. The announcement sent RTIX shares up 12% by around 4 p.m. after the announcement on Wednesday, September 11, when they were trading at $3.93, up from an open price of $3.56.

Help employers find you! Check out all the jobs and post your resume.

Back to news